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Glycerol kinase from Escherichia coli, but not Haemophilus influ-
enzae, is inhibited allosterically by phosphotransferase system
protein IIAGlc. The primary structures of these related kinases
contain 501 amino acids, differing at 117. IIAGlc inhibition is trans-
planted from E. coli glycerol kinase into H. influenzae glycerol
kinase by interconverting only 11 of the differences: 8 residues that
interact with IIAGlc at the allosteric binding site and 3 residues in
the conserved ATPase catalytic core that do not interact with IIAGlc
but the solvent accessible surface of which decreases when it
binds. The three core residues are crucial for coupling the allosteric
site to the conserved catalytic core of the enzyme. The site of the
coupling residues identifies a regulatory locus in the sugar kinase
heat shock protein 70actin superfamily and suggests relations
between allosteric regulation and the active site closure that
characterizes the family. The location of the coupling residues
provides empirical validation of a computational model that pre-
dicts a coupling pathway between the IIAGlc-binding site and the
active site [Luque, I. & Freire, E. (2000) Proteins Struct. Funct. Genet.
Suppl. 4, 63–71]. The requirement for changes in core residues to
couple the allosteric and active sites and switching from inhibition
to activation by a single amino acid change are consistent with a
postulated mechanism for molecular evolution of allosteric
regulation.
A llosteric regulation of enzyme catalysis is a fundamentalaspect of control in biological systems. For most classically
studied allosteric enzymes (1), catalytic activity is modulated by
small molecules such as fructose 1,6-bisphosphate (FBP), phos-
phoenolpyruvate, or nucleotides. The regulatory binding sites
and the active sites are located at subunit–subunit interfaces of
the homooligomeric proteins and are separated by 10 Å.
Substrate binding shows homotropic interactions, typically pos-
itive cooperativity. Allosteric effectors change the affinity for
substrates at the active sites but do not affect Vmax. Allosteric
inhibition decreases apparent affinity for substrate, and activa-
tion increases apparent affinity. Changes in quaternary struc-
ture, involving small rigid-body rotations and translations of
subunits, are seen in crystal structures of the enzymes with
substrates or allosteric effectors. Regulation of catalysis by
protein–protein interactions is less understood but seems to be
the rule rather than the exception, and there is widespread
interest in interactomes and roles of macromolecular interac-
tions in living systems (2). A related area of interest is the
molecular evolution of allosteric control by protein–protein
interactions. Here we show that transplantation of allosteric
regulation from one enzyme to another provides insights into
how protein–protein interactions distant from an active site
regulate catalysis and into mechanisms of molecular evolution.
Glycerol kinase (EC 2.7.1.30; ATP:glycerol 3-phosphotrans-
ferase) from Escherichia coli (EcGK) is a regulatory enzyme (3).
It is inhibited allosterically by IIAGlc, the 18-kDa glucose-specific
phosphocarrier protein of the phosphoenolpyruvate:glycose
phosphotransferase system (4). Binding of IIAGlc decreases Vmax
and the substrate Michaelis constants, and no cooperativity is
observed for inhibition or with respect to glycerol or MgATP (5).
Thus, in contrast to classically studied regulatory enzymes,
IIAGlc inhibition of EcGK shows decreased Vmax, increased
apparent substrate affinity, and no homotropic interactions for
any of the ligands. X-ray crystallographic studies of the protein–
protein complex show that EcGK is a homotetramer with one
molecule of IIAGlc bound per 56-kDa subunit (Fig. 1A; refs. 6
and 7). The allosteric site is on the subunit surface more than 30
Å from the catalytic site and not at a subunit–subunit interface.
The structure of the complex elicits the question of how binding
of a regulatory protein to the subunit surface distant from the
catalytic site produces the regulation of catalysis that is observed
for EcGK. However, typical approaches to addressing this
question have not yielded a complete answer.
Crystallographic studies do not provide a complete structural
description of IIAGlc inhibition. They verify that EcGK is a
member of the sugar kinaseheat-shock protein 70actin super-
family of enzymes, the members of which fulfill many important
functions (8). Superfamily members have a conserved ATPase
catalytic core, consisting of the motif 12314253 in each
domain (Fig. 1 A). A hallmark of the superfamily, exemplified by
hexokinase in glucose binding, is a conformational change that
involves relative motion of two domains (I and II) to close the
active site cleft. Thus, the active site is located at a domain–
domain interface within a single subunit. The closure has been
characterized as a domain-shear motion involving movement of
the 3 element in each domain relative to the same element in
the other and movement of the core -sheet in each domain
relative to the 3 element of the other (9). Posttranslational
regulation of the function of many of the family members is
believed to involve modulation of this motion. Crystallographic
studies of EcGK show evidence for conformational changes
associated with active site closure and induced fit of amino acids
that bind IIAGlc but do not show how these two conformational
changes are coupled (10, 11). The conformation of IIAGlc does
not change after binding to EcGK.
Phylogenetics studies of this family (12) do not provide further
insights into the allosteric regulation. Only EcGK and the
essentially identical enzymes from Salmonella are known to be
inhibited by IIAGlc. Thus, there are not multiple examples of
regulated enzymes that show conserved amino acids to identify
molecular coupling pathways (13). However, these studies iden-
tify sugar kinases related to EcGK. The existence of these related
enzymes suggests the use of transplantation of IIAGlc inhibition
into a naive enzyme as a gain-of-function approach to identify
amino acid differences in EcGK that give rise to IIAGlc allosteric
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control and to investigate mechanisms of molecular evolution of
allosteric control.
Transplantation of allosteric regulation has been used in
hemoglobins (14). The molecular basis for bicarbonate-ion
control of the oxygen affinity of crocodilian hemoglobin was
postulated from primary structure comparisons and tested by
site-directed mutagenesis. Bicarbonate-ion control can be trans-
planted to human hemoglobin by 12 amino acid substitutions to
generate a putative bicarbonate-ion binding site at the tetramer
interface. Although the ion binding site was not verified struc-
turally, the transplantation indicates that functionally important
loci can be identified from amino acid replacements necessary to
elicit a new function. Thus, a subset of the amino acids that
participate in IIAGlc inhibition of EcGK may be identified as the
replacements from EcGK into a naive enzyme that are necessary
to transplant inhibition.
A family member closely related to EcGK is glycerol kinase
from Haemophilus influenzae (HiGK). It contains 502 amino
acid residues, one more than EcGK, and the primary structures
are 87% similar (76% identical). Homology modeling (ref. 15;
www.expasy.ch) of the HiGK sequence to the known structure
of EcGK gives overall root-mean-square deviation of the back-
bone atoms of 0.43 Å, consistent with the high degree of
similarity. Locations of the 117 amino acid differences are shown
in Fig. 1B. We purified HiGK and characterized its catalytic and
regulatory properties (16). Both EcGK and HiGK are inhibited
allosterically by FBP. Crystallographic studies of EcGK show
two FBP-binding sites per tetramer located at subunit–subunit
interfaces (17). The binding site for FBP on EcGK is located in
domain I on the opposite side of the subunit from the binding site
for IIAGlc, and the FBP-binding amino acid residues are con-
served in the H. influenzae enzyme (Fig. 1C). In solution, EcGK
shows an equilibrium between homodimers and homotetramers
(18), and FBP inhibition requires tetramer formation (19).
Sedimentation velocity ultracentrifugation shows that HiGK
sediments more slowly than EcGK in the absence of FBP,
suggesting the presence of a greater fraction of dimer but about
the same as EcGK in the presence of FBP. The catalytic,
structural, and FBP regulatory behavior of HiGK is similar
to EcGK, but IIAGlc regulation is different. Eight of the eleven
EcGK amino acids that interact with IIAGlc are different in
HiGK, and it is not inhibited by E. coli IIAGlc. This lack of
inhibition could indicate complementary substitutions in H.
influenzae IIAGlc, but its sequence is highly similar to the E. coli
IIAGlc (82% similarity72% identity), and all the amino acids
that interact with EcGK (7) are identical in H. influenzae IIAGlc.
Although it has not been tested, inhibition of HiGK by its own
IIAGlc is unlikely, and roles for IIAGlc in the regulation of
glycerol metabolism in H. influenzae have not been described.
Allosteric inhibition of EcGK by FBP and IIAGlc operate
independently, and IIAGlc inhibition does not require tetramer
formation (19–21). Thus, HiGK is naive with respect to allosteric
control by E. coli IIAGlc.
In the simplest case, replacement of only the eight different
interacting amino acid residues in HiGK with those from EcGK
would be sufficient to transplant IIAGlc inhibition. However, we
show that this is not the case. Transplantation of IIAGlc inhibi-
tion into HiGK requires substitution of three amino acid residues
of the conserved ATPase catalytic core, and IIAGlc inhibition of
EcGK can be switched to activation by changing one of these
residues. The replacement of amino acids in the conserved core
to couple the IIAGlc binding site to the catalytic site and the
switching behavior provide experimental verification of a pos-
tulated mechanism for evolution of allosteric enzyme regulation
(22, 23). The coupling locus is identical topologically to the
FBP-binding site in domain I and is consistent with a molecular
pathway that is predicted by a structure-based computational
method to couple IIAGlc binding and the active site (24),
Fig. 1. Ribbon diagrams of the structure of one EcGK subunit with bound
IIAGlc. IIAGlc is shown in magenta, and EcGK is shown in the remaining colors.
(A) The conserved ATPase catalytic core. Glycerol is shown in green in the
active site. Domain II, which contains the IIAGlc binding site, is to the left of the
cleft, and domain I is to the right. The conserved ATPase motif in domain I is
shown in red and in domain II in gray. The secondary structure elements3 and
5 are labeled in each domain. (B) Amino acid differences in EcGK and HiGK.
Identities are shown in blue, conservative substitutions in red, and noncon-
servative substitutions in gold. The N- and C-terminal positions are labeled 1
and 501, respectively, and selected residue positions are numbered. (C) The
location of amino acid substitutions required to transplant IIAGlc inhibition to
HiGK. The amino acids that interact directly with IIAGlc are shown as stick
models in red. Amino acids 427–429 in EcGK (GTR) are shown in green and in
HiGK (DVN) are shown in gold. D427 is labeled D and R429 is labeled R.
Conserved ATPase catalytic core elements are colored as described for A. The
loop with the binding site for FBP in domain I is shown in green and labeled
FBP. The images were generated from PDB ID code 1gla by using SWISS-PDB VIEWER
3.5 (15) and rendered by using POV-RAY 3.1 for WINDOWS (www.povray.org).
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suggesting a relation between the proposed domain-shear mo-
tion and molecular mechanisms for allosteric regulation of
superfamily members. The coupling amino acid residues in
EcGK do not interact with IIAGlc but do undergo changes in
solvent-accessible surface area after complex formation, sug-
gesting that such changes play crucial roles in protein–protein
regulatory interactions.
Methods
Materials. General reagents, phosphoenolpyruvate, NADH,
pyruvate kinase, and lactate dehydrogenase were purchased
from Sigma. Restriction enzymes and T4 DNA ligase were
purchased from Promega. IIAGlc was generously supplied by
Saul Roseman and Norman D. Meadow of the Department of
Biology at The Johns Hopkins University (Baltimore).
Construction of Site-Directed Variants and Chimera. The plasmids
harboring the genes for the chimeric enzymes H:E245 and
E:HII245 were constructed by ligation of DNA fragments gen-
erated from EcoRI, HindIII, and BstEII restriction endonucle-
ase digestion of the plasmids harboring the genes for the parent
enzymes.‡ Plasmids harboring the genes for the chimeric en-
zymes HII::E353– 450, HII::E423– 442, and revertants of
HII::E423–442 were constructed following the ExSite protocol of
Stratagene. The remaining plasmids harboring genes for chi-
meric enzymes were constructed by using overlap extension PCR
(25). The coding regions for all chimeric enzymes were se-
quenced and found to possess the expected sequences.
Protein Purification. HiGK was purified as described (16). All
other glycerol kinases were purified essentially as described (21),
with the following changes: only the first two chromatography
steps were needed for H:E245; only the first chromatography
step was needed for HiGKII, HiGKII–GTR, and HiGK–GTR,
with the modification that samples were loaded in the absence
of added salt and eluted by a 0.1 M KCl step gradient; and an
additional chromatography step using phenyl-Sepharose (26)
was needed for HiGKII–D427G.
Kinetic Assays. Enzyme assays were performed and analyzed as
described (16) by using an ADP-coupled spectrophotometric
assay at pH 7.0 and 25°C. A unit is defined as the amount of
glycerol kinase that produces 1 mol of ADP per min in this
assay. For determination of KATP, the glycerol concentration was
2 mM; for determination of Kgol, the ATP concentration was 1
mM for H:E245, 0.7 mM for HiGK–GTR, 0.5 mM for HiGK,
HiGKII–GTR, and HiGKII–D427G, 0.3 mM for HiGKII, and 0.1
mM for EcGK, EcGK–G427D, and EcGK–DVN.
For IIAGlc inhibition assays, ATP and glycerol concentrations
were 2.5 and 2 mM, respectively, IIAGlc concentrations varied
from 0 to 27 M, and 0.1 mM ZnCl2 was added to the assays.
Inhibition data were fitted to a normalized hyperbolic function:
SA,%  100  [100  (Imax  [IIAGlc])K50  [IIAGlc])], where
SA,% is the percent remaining activity of the enzyme at a
particular inhibitor concentration compared with the activity
with no effector present, Imax is the maximal percent inhibition,
and K50 is the apparent dissociation constant for effector bind-
ing. The data were fitted by using KALEDIAGRAPH 3.09 for
WINDOWS (Synergy Software, Reading, PA).
Sedimentation Velocity Ultracentrifugation. These experiments
were performed as described (27) by using a Beckman Model
XL-A analytical ultracentrifuge at 35,000 rpm and 25°C. The
concentration of glycerol kinase was 5 M (subunits), and that
of IIAGlc, when present, was 35 M. ZnCl2 was included in all
buffers at 10 M. Data were analyzed and the sedimentation
coefficient was determined by using the program SVEDBERG 6.38
by John Philo (28).
Results and Discussion
Substitution of the IIAGlc-Interacting Amino Acids Is Not Sufficient to
Transplant IIAGlc Control. Crystallographic studies identify 11
amino acids of EcGK that interact with IIAGlc: R402 and
P472GIETTERNY481 (7). Amino acid 402 is the same in both
enzymes, but 8 of the 10 sequentially contiguous amino acids are
different (P472DSDNEKRER481, with differences underlined;
ref. 16). To determine whether substitution of the interacting
EcGK residues into HiGK results in transplantation of IIAGlc
inhibition, the chimeric enzyme, HiGKII was constructed (Table
1). The catalytic activity of HiGKII, similar to its HiGK parent,
is not altered detectably by IIAGlc. The kinetic parameters and
allosteric inhibition by FBP (not shown) are little altered by the
substitutions, indicating that they do not perturb the enzyme
structure greatly.
Sedimentation velocity ultracentrifugation (as described un-
der Methods) was used to evaluate IIAGlc binding (Table 2). The
sedimentation coefficient of HiGKII is the same as that of HiGK,
further showing that the substitutions do not perturb the struc-
ture greatly. The addition of IIAGlc increases the sedimentation
coefficient for EcGK but does not alter the sedimentation
‡Chimeric enzyme nomenclature: The chimeric enzymes are named according to the
portions of primary structure from each of the parent enzymes; for example, H:E245 is
joined at amino acid 245 with the N-terminal portion from HiGK and the C-terminal
portion from EcGK, and HII::E423–442 is constructed by replacing amino acids 423–442 in
HiGKII with those from EcGK. The II denotes the amino acid residues identified crystallo-
graphically to interact with IIAGlc (7). Single-letter amino acid abbreviations following a
hyphen after the name of the chimera, e.g., HiGK–GTR, show the identities of the residues
at positions 427–429. Individual amino acid substitutions are denoted by using the
single-letter abbreviations, e.g. G427D indicates replacement of the glycine at 427 by
aspartate.
Table 1. Catalytic and regulatory properties of chimeric enzymes
Enzyme*
Kinetic parameters IIAGlc inhibition†
Vmax,
unitsmg Katp, M Kgol, M Imax, % K50, M
EcGK 13  1 6  1 9  1 94  1 0.5  0.1
HiGK 21  1 45  6 34  2 n.e. n.e.
HiGKII 9  1 24  3 34  2 n.e. n.e.
HiGKII–GTR 25  2 46  8 33  2 69  1 2.0  0.1
H:E245 37  1 19  1 17  1 74  1 0.7  1
HiGK–GTR 20  2 73  12 48  3 n.e. n.e.
EcGK–DVN 10  1 3  1 3  1 15  2 2  0.9
EcGK–G427D 9  1 3  1 3  1 14  2 6  3
HiGKII–D427G 23  3 69  15 62  3 80  14 29  8
Steady-state kinetic and regulatory properties of the purified enzymes
were determined as described under Methods.
*HiGKII contains substitutions of the amino acids from EcGK in the sequentially
contiguous portion of the IIAGlc binding site (positions 472–481): HiGK,
PDSDNEKRER; HiGKII, PGIETTERNY. Additional substitutions at positions
427–429 are shown after the hyphen.
†n.e., no effect.
Table 2. Binding of IIAGlc to glycerol kinases: Sedimentation
velocity ultracentrifugation
Enzyme
Sedimentation coefficient, S
IIAGlc IIAGlc
EcGK 10.2  0.1 12.5  0.1
HiGK 6.7  0.1 6.8  0.1
HiGKII 6.6  0.1 6.5  0.1
HiGKII–GTR 6.8  0.1 7.8  0.1
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coefficient of HiGK or HiGKII, which is consistent with binding
of IIAGlc to EcGK but not to the other two enzymes. The
detection limits of this method indicate that the affinity for
IIAGlc binding to these enzymes is at least 200-fold less than for
EcGK. Thus, substitution of the interacting amino acids from
EcGK is not sufficient to transplant IIAGlc binding, hence
allosteric control.
Identification of Additional Substitutions That Are Required to Trans-
plant IIAGlc Inhibition. Fig. 1B shows that the 117 primary structure
differences between EcGK and HiGK occur in both domains, 69
in domain II, and in the conserved catalytic core and regions
outside the core. To identify the adaptive substitutions, a series
of chimeric enzymes was constructed to determine portions of
the primary structure that must be interchanged to transplant
IIAGlc inhibition (Fig. 2). All the chimeric enzymes containing
EcGK amino acids 423–442 in addition to the interacting amino
acids from EcGK are inhibited by IIAGlc. For those that contain
the amino acids from HiGK at positions 423–442, inhibition by
IIAGlc could not be detected, i.e., less than 3% inhibition,
indicating that the apparent affinity is at least 100-fold less than
that for EcGK.
There are six amino acid differences between HiGKII and
EcGK in this region: positions 423, 427–429, 434, and 436. The
contribution of each of these differences was assessed by using
the chimeric enzyme HII::E423–442, which has the amino acids
from EcGK at these positions. Each of these amino acids in the
chimeric enzyme was reverted individually to the amino acid in
HiGK, and the response of the enzyme to IIAGlc was determined
(Table 3). The reversions at positions 427–429 show substantial
effects on inhibition by IIAGlc, whereas those at the other three
positions show little or no effect. The revertant G427D shows
activation instead of inhibition. It is important to note that the
absence of substantial effects for revertants at the other positions
does not indicate that they do not participate in IIAGlc binding
and inhibition. The small but significant decrease in inhibition
seen for the R436K revertant, a conservative substitution, indicates
that this residue indeed has a role in IIAGlc inhibition, but its
replacement is not necessary to transplant the inhibition.
Based on the greater sensitivity of IIAGlc inhibition to the
reversions at positions 427–429, the variant HiGKII–GTR, in
which EcGK amino acids replace the HiGK amino acids at
positions 473–481 and 427–429, was constructed. It shows
substantial inhibition by IIAGlc, whereas its catalytic properties
differ little from those of EcGK, HiGK, or HiGKII (Table 1). The
apparent affinity for IIAGlc is 4-fold less and the maximum
inhibition by IIAGlc is less than that for EcGK. These parameters
agree well with those for the H:E245 chimeric enzyme (Table 1),
showing that most of the contribution of the 69 domain II
differences to IIAGlc inhibition is obtained with only 11 substi-
tutions. The parameters also agree well with those obtained for
the chimeric enzyme HII::E423–442 (Table 3), further support-
ing the conclusion that substitutions of the other three different
amino acids (423, 434, and 436) are not necessary to transplant
IIAGlc inhibition. The differences between HiGKII–GTR and
HII::E423–442 at these three positions do not account for the
lower affinity and extent of inhibition relative to EcGK. Binding
of IIAGlc to HiGKII–GTR can be detected in the sedimentation
velocity ultracentrifugation assay (Table 2). Thus, IIAGlc binding
and regulation of catalysis are highly interdependent. The in-
crease in the sedimentation coefficient for HiGKII–GTR is
about one-half that obtained for EcGK. This smaller increase
suggests that IIAGlc does not alter the oligomeric state of
HiGKII–GTR, which is consistent with the independence of
IIAGlc inhibition and dimer–tetramer assembly seen for
EcGK (19).
To determine whether the changes at positions 427–429 alone
are sufficient to transplant IIAGlc inhibition, the variant HiGK–
GTR was constructed. This variant retains the HiGK amino
acids at positions 473–481 and is not inhibited by IIAGlc (Table
1). Substitution of HiGK amino acids with those from EcGK at
positions 427–429 is necessary but not sufficient for IIAGlc
inhibition. Thus, substitution of only 11 of the 117 different
amino acids from EcGK into HiGK is necessary and sufficient
to transplant substantial IIAGlc inhibition.
The variant EcGK–DVN, in which the amino acids at positions
427–429 in EcGK are replaced with those from HiGK, is the
converse of HiGKII–GTR. It was constructed to determine
whether these substitutions are sufficient to abolish IIAGlc
binding and inhibition as seen for HiGKII, which has DVN at
these positions. The EcGK–DVN variant binds IIAGlc, and its
apparent affinity is 4-fold less than EcGK, which is about the
same as for HiGKII–GTR (Table 1). However, it displays greatly
altered behavior with respect to IIAGlc action, which is switched
from inhibition to activation. Activation by IIAGlc was observed
for the revertant HII::E423–442–G427D (Table 3). This rever-
tant corresponds to the variant EcGK–G427D, in which only
amino acid 427 is replaced with the corresponding one from
Fig. 2. Identification of EcGK primary structure that transplants IIAGlc inhi-
bition to HiGK. The primary structure of EcGK is represented by the thicker
line, and that of HiGK is represented by the thinner line. Chimeric enzymes
were constructed as described under Methods. IIAGlc inhibition was assessed
by determining the specific activity of glycerol kinase in cell extracts without
and with the addition of IIAGlc to the assay. , IIAGlc inhibits the chimeric
enzyme; , no IIAGlc inhibition observed.
Table 3. Contributions of EcGK amino acids 423–436 to IIAGlc
inhibition of chimeric enzyme HII::E423–442
Amino acid substitution
in HII::E423–442* vivo
None† 0.50
S423A 0.50
G427D 1.12
T428V 0.38
R429N 0.22
E434V 0.52
R436K 0.46
Glycerol kinase activity in crude cellular extracts was determined in dupli-
cate without and with 10 M IIAGlc added to the assay and corrected for
glycerol-independent background rates. IIAGlc inhibition is expressed as the
ratio of the reaction velocity with IIAGlc, vi, to the velocity without IIAGlc, vo.
Duplicate values for vivo differed from the reported average value by 0.01 or
less.
*Amino acid substitutions in this chimeric enzyme are shown by using the
single-letter abbreviations and sequence number, where the amino acid
replacement is the residue in HiGK.
†Determination of the IIAGlc concentration dependence of inhibition for the
HII::E423–442 parent enzyme yielded K50  3  0.2 M and Imax  65  1%.
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HiGK. The apparent role of amino acid 427 in activation by
IIAGlc was verified by constructing the variant EcGK–G427D.
This variant shows activation rather than inhibition by IIAGlc,
and the apparent affinity for IIAGlc is decreased 11-fold (Table
1). Thus, the converse substitution of HiGK amino acids for
EcGK at 427–429 does not abolish IIAGlc binding but switches
its effect from inhibition to activation, and the substitution
G427D in EcGK is sufficient for the switching.
The variant HiGKII–D427G was made to evaluate the extent
to which D427 is responsible for the lack of IIAGlc binding to
HiGKII. It retains the amino acids from HiGK at positions 428
and 429 but has the glycine from EcGK at position 427. This
variant is inhibited by IIAGlc; however, the apparent affinity for
IIAGlc is 15-fold less than that of HiGKII–GTR (Table 1).
Thus, the single substitution, D427G, in combination with the
interacting residues is sufficient for IIAGlc binding and inhibi-
tion, but the amino acids at positions 428 and 429 make
significant contributions to the affinity for IIAGlc. Contributions
of these two positions are seen also in the T428V and R429N
revertants of HII::E423–442 (Table 3). The revertants show
decreased inhibition, which is consistent with the reduced af-
finity seen for HiGKII–D427G.
Crystallographic studies show that the conformations of
EcGK residues 474–478 undergo induced-fit transitions between
coil, 310 helix, and -helix upon IIAGlc binding (11). Alanine
substitutions at positions 479–481, which are -helical in the
absence or presence of IIAGlc, result in large decreases in affinity
that are consistent with stabilization of the -helix, affecting
positions that undergo the conformational changes (29). On the
basis of the earlier reports, the lack of detectable IIAGlc binding
to HiGKII strongly suggests that this region is unable to undergo
the induced fit, and the IIAGlc binding that is observed after
substitution of the amino acids at 427–429 strongly suggests that
the conformational change is then possible. Verification of the
conformation in this region will require crystallographic studies.
Additional conformations may be observed, given the switching
from inhibition to activation that is obtained depending on the
identity of the amino acid at position 427.
Positions 427–429 Couple IIAGlc Binding to the Conserved ATPase
Catalytic Core and Identify a Key Regulatory Locus in Both Domains.
Positions 427–429 are critical for the binding of IIAGlc and
coupling to the active site. Crystal structures show that these
amino acids do not form interactions with IIAGlc, and there is no
change in conformation in this region after IIAGlc binding that
is discernible at the 2.4–3.0-Å resolutions of the structures (7, 10,
11). No atoms of the amino acids at 427–429 are closer than 4.3
Å to IIAGlc, and no IIAGlc amino acid side chains form polar
interactions with these amino acids. Analysis of accessible
surface areas of these amino acids shows that IIAGlc occludes
them from solvent (E. Freire, personal communication). Their
accessible surface areas in the absence and presence of IIAGlc in
the EcGK–IIAGlc complex (PDB ID code 1gla, 2.6-Å resolution)
were calculated according to the Lee and Richards algorithm
by using a probe radius of 1.4 Å and a slice width of 0.25 Å (30).
The accessible surface area of the amino acids at positions 427
and 429 is decreased by a total of 47 Å2 (6% of the total buried
surface area) in the presence of IIAGlc. Thus, amino acid residues
that undergo changes in solvent-accessible surface area but do
not make intermolecular contacts can play critical roles in
binding and allosteric regulation. This may be an important,
previously uncharacterized aspect of protein–protein regulatory
interactions relative to small molecule allosteric effectors.
The location of amino acids 427–429 in EcGK provides
insights into their critical role in IIAGlc regulation (Fig. 1C). It
is in the conserved ATPase catalytic core, connecting the
elements 2 and 5 in domain II. Thus, the substitutions at
427–429 in HiGKII–GTR represent changes in the core neces-
sary for IIAGlc to bind and for coupling the binding to inhibition.
These residues are located on the subunit surface at the distal
end of element 5, which connects them directly to element 3,
an active site -helix which is proposed to move during the
domain-shear motion that closes the active site (9). The exper-
imentally determined importance of amino acids 427–429 in
IIAGlc inhibition of EcGK verifies computational studies of
Freire and coworkers (24, 31, 32). Their results predict that
element 5 of domain II is the primary pathway that couples the
IIAGlc binding site to structural stability at the active site,
specifically helix 3.
The binding site for FBP in domain I is identical topologically
to that for IIAGlc in domain II (Fig. 1C; refs. 7 and 17). Thus,
427–429 and the FBP site identify a regulatory locus that is
common to the conserved catalytic core motif in each domain.
Regulatory interactions at this locus in each case can result in
inhibition or activation. As shown here, if the glycine at 427 in
EcGK is replaced by aspartate, activation rather than inhibition
is obtained. In the case of the related glycerol kinases from
Gram-positive bacteria, phosphorylation at the locus corre-
sponding to the FBP-binding site results in activation of catalysis
(33). For both 427–429 and the FBP site, the locus is a junction
between the conserved catalytic core and additions or insertions
that expand the functions of the core. Positions 427–429 are at
a junction between the core and the C-terminal addition sub-
domain IIC (positions 451–501), which forms a substantial
portion of the dimer interface. The FBP site is at a junction
between the core and insertion subdomain IC. In each case, the
subdomain forms a layer of structure above the layer that is
formed by the conserved 1 and 2 elements. In the proposed
domain-shear motion, the 1 and 2 elements move with the
-sheet in each domain (9). The importance of interactions
between the layers is indicated by the effect of a single amino
acid substitution in EcGK on IIAGlc inhibition (20). The substi-
tution G304S alters interactions between the conserved -sheet
and element 1 in domain II and switches the effect of IIAGlc to
activation. The location of the common regulatory locus in each
domain suggests that the allosteric control is mediated through
changes in the motion of the subdomain relative to the conserved
core elements. However, structural constraints that arise from
the necessity for maintaining the tertiary structure of the subunit
preclude large shifts in conformation and different interdigitat-
ing side chain patterns between the layers, such that small
motions are sufficient for catalytic control. Thus, for this widely
distributed protein superfamily, small motions between layers of
secondary structure in the subunit seem to have the same roles
as the rigid-body rotations and translations of entire subunits
observed for classically studied regulatory enzymes.
It is important to note that the transplanted amino acids
identify only differences between EcGK and HiGK that have to
be changed to obtain IIAGlc inhibition. Doubtless, several of the
many identical and conserved amino acid positions also are
important for allosteric control. In particular, elements of the
conserved catalytic core must have roles. The transplanted
amino acids thus identify only a subset of the positions that are
involved in allosteric regulation of glycerol kinases by IIAGlc.
However, they represent a key subset in the evolution of that
allosteric control that is necessary for generating the allosteric
binding site and coupling it to the conserved catalytic core.
Molecular Evolution of Allosteric Regulation. A mechanism for
molecular evolution of allosteric regulation was postulated on
the basis of structural and phylogenetic studies of glycogen
phosphorylases (22, 23). Acquisition of 5-AMP activation of
vertebrate glycogen phosphorylase is thought to require amino
acid substitutions at a preexisting site for the allosteric inhibitor
glucose 6-phosphate to generate a site for 5-AMP. In addition,
substitutions to modify interactions between secondary struc-
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tural elements of the conserved catalytic core generate a
‘‘switch’’ that allows 5-AMP binding to activate, and glucose
6-phosphate binding to inhibit, catalysis at the distant active site.
This core-coupling mechanism for acquisition of 5-AMP acti-
vation of vertebrate glycogen phosphorylase has not been tested
by gain-of-function studies. Furthermore, the proposal involves
modification of an existing regulatory mechanism rather than
acquisition of regulation by a naive enzyme.
The binding site for IIAGlc on EcGK is primarily on a
C-terminal addition onto the last 3 element of the conserved
motif of domain II, termed subdomain IIC (amino acids 451–
501; ref. 7). The portion of the addition that is located C-
terminally to the IIAGlc binding site is a long -helix that forms
a substantial portion of the subunit–subunit interface in the
dimer. The three members of the sugar kinase family that
have been characterized, EcGK (18), HiGK (16), and E. coli
L-ribulokinase (34), form dimers, but only EcGK is inhibited by
IIAGlc (16). Molecular evolution of these family members thus
may have involved a gene-fusion event to give a C-terminal
addition to the conserved ATPase core and allow dimer forma-
tion. Results presented here show that a few amino acid substi-
tutions in the conserved core can couple binding of IIAGlc on this
addition to modulation of catalysis at the active site and a single
amino acid change is sufficient to switch the modulation from
inhibition to activation with only modest effects on binding
affinity. The experimental results from gain-of-function studies
reported here thus are consistent with the postulated mechanism
for molecular evolution of allosteric regulation. The same mech-
anism seems, as expected, to account for molecular evolution of
allosteric regulation by both small molecules and protein–
protein interactions.
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